Similarly, in the pivotal multicenter study of Sidransky et al., GBA1 pathogenic mutations were present in 9.4% of PD and 0.37% of controls, resulting in a remarkable odds ratio (OR 25.4) [7]. Here, GBA1 is linked to Parkinson disease.